Search results for:
Steriwave deploying in eight new sites
Steriwave deploying in eight new sites Vancouver, British Columbia, Canada - March 15, 2024 Ondine Biomedical Inc. (LON:OBI), the Canadian life sciences company pioneering light-activated antimicrobial treatments to prevent and treat healthcare-associated infections (HAIs), has made significant commercial progress to date in 2024, ahead of [...]
Ondine starts first UK health economics study
The York Health Economics Consortium will undertake the first UK health economic analysis of Ondine’s Steriwave light-activated antimicrobial to reduce surgical site infections Vancouver, British Columbia, Canada - March 5, 2024 Ondine Biomedical Inc. (LON:OBI), Mid Yorkshire Teaching NHS Trust, and Health Innovation Yorkshire and [...]
Microbiome research supports use of Steriwave
Ondine Biomedical demonstrated that photodisinfection does not harm the nasal microbiome Vancouver, British Columbia, Canada - January 31, 2024 Research presented by Canadian life sciences company, Ondine Biomedical Inc. (LON:OBI), at the prestigious SPIE Photonics West conference in San Francisco, California shows that treatment with [...]
Ondine unveils new research at SPIE Photonics West
Ondine unveils new research at SPIE Photonics West Vancouver, British Columbia, Canada - January 26, 2024 Canadian life sciences company Ondine Biomedical Inc. (LON: OBI) will present new research at the SPIE Photonics West conference in San Francisco, California. The presentation will provide details of an [...]
Successful C$4.91M raise supports ongoing commercialisation
Ondine successfully raised C$4.91 million to support acceleration of its commercial rollout of nasal decolonization to prevent healthcare-associated infections Vancouver, British Columbia, Canada - December 13, 2023 Ondine met its 2023 target and more than doubled the number of hospitals using its groundbreaking photodisinfection [...]
Steriwave featured in the Daily Mail
Daily Mail news feature: Shining a red light up a patient's nose is being tested as a new way to prevent infections in surgical incisions. The new approach, being trialled in a UK hospital, is based on previous research which shows this kind of light therapy can cause a reaction [...]
Photodisinfection recommended as Standard of Care
Peer-reviewed publication involving 13,493 patients reports 66.5% decrease in spine surgery infection rate sustained over 8 years with the use of Steriwave® nasal photodisinfection Vancouver, British Columbia, Canada - November 16, 2023 Canadian life sciences company, Ondine Biomedical Inc. (OBI: LON), reports that an [...]
Steriwave named as SPIE Prism Awards finalist
Nasal photodisinfection named as leading photonics biomedical technology for its potential to safely combat AMR Vancouver, British Columbia, Canada - November 10, 2023 Ondine Biomedical’s Steriwave nasal photodisinfection technology has been shortlisted in the biomedical category of the 2024 international society for optics and photonics [...]
Steriwave use expanded following successful pilot
Alberta Health Services has expanded its use of Steriwave nasal photodisinfection to reduce the incidence of surgical site infections (SSIs) in orthopedic surgery following a successful pilot at the Mazankowski Alberta Heart Institute Vancouver, British Columbia, Canada - October 31, 2023 SSIs, the most [...]
66.5% reduction in spine surgery infection rate
Pre-surgical Steriwave® nasal photodisinfection protocol contributed to 66.5% reduction in spine surgery infection rates and $2.5 million annual savings in Vancouver General Hospital Vancouver, British Columbia, Canada - October 23, 2023 Canadian life sciences company, Ondine Biomedical Inc. (OBI: LON), reports new independent research findings [...]
For Media Information
Simon Vane Percy
Amanda Bernard
